Form 4: Erasca Director Opts for Stock Options Over Cash

Erasca, Inc. Director Jean I. Liu received 20,617 stock options with an exercise price of $3.72 in lieu of 2026 cash compensation.

Summary

• Director Jean I. Liu acquired 20,617 stock options of Erasca, Inc. on January 1, 2026.
• The options have an exercise price of $3.72 per share and expire on January 1, 2036.
• This grant was issued in lieu of cash compensation payable to the director for her service on the board of directors and its committees in 2026.
• The options will vest and become exercisable in monthly, cumulative 1/12 increments beginning one month from the grant date, subject to continued board service.

Sentiment

Score: 7

Explanation: The director's decision to take equity instead of cash compensation is generally viewed positively as it aligns their interests with shareholders, suggesting confidence in the company's future. The long vesting period further reinforces this alignment.

Positives

• Director opting for equity over cash compensation demonstrates alignment of interests with shareholders, signaling confidence in the company's future.
• The long-term vesting schedule (10 years expiration, monthly vesting) encourages sustained commitment to the company's performance and strategic goals.

Future Outlook

The vesting schedule of the stock options, which occurs in monthly increments over time, indicates an expectation for the director's continued service on the board and commitment to the company's long-term success.

Industry Context

This type of equity compensation for directors is a common practice in the biotechnology and pharmaceutical industry, aligning director incentives with shareholder value creation, particularly for growth-oriented companies like Erasca.

Related Party Transactions

• Director Jean I. Liu received 20,617 stock options in lieu of cash compensation for her service on the board and its committees in 2026. This represents a transaction between the company and a director.

Stakeholder Impact

• Shareholders: The decision by a director to accept equity compensation over cash can be seen as a positive signal, indicating confidence in the company's future performance and aligning the director's financial interests with those of shareholders.

Next Steps

• The stock options will begin vesting in monthly 1/12 increments one month from the grant date (February 1, 2026, assuming grant on Jan 1, 2026).
• The director is anticipated to continue serving on the issuer's board of directors and its committees in 2026.

Key Dates

Recommendation

While the director's decision to take equity over cash is a positive signal of alignment and confidence, a single Form 4 filing typically does not provide enough comprehensive information to warrant a 'buy' or 'strong buy' recommendation. It reinforces a 'hold' position for existing investors and suggests a positive indicator for those considering the stock, but further fundamental analysis would be required for a stronger recommendation.

Keywords

Erasca, ERAS, Form 4, Insider Trading, Stock Options, Director Compensation, Equity Compensation, Beneficial Ownership, Jean I. Liu